{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:28:58Z","timestamp":1786487338509,"version":"build-2736575974"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02683","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T04:37:26Z","timestamp":1542688646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Dysregulated miR-155 and miR-125b Are Related to Impaired B-cell Responses in Down Syndrome"],"prefix":"10.3389","volume":"9","author":[{"given":"Chiara","family":"Farroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Marasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Marcellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"D'Oria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pezzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Cascioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Scarsella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto G.","family":"Ugazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni C.","family":"De Vincentiis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Grimsholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Carsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12929-015-0138-y","article-title":"Down syndrome: an insight of the disease","volume":"22","author":"Asim","year":"2015","journal-title":"J Biomed Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.prrv.2017.07.003","article-title":"The evaluation and management of respiratory disease in children with Down syndrome (DS)","volume":"26","author":"Alsubie","year":"2018","journal-title":"Paediatr Respir Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/dmcn.12180","article-title":"Sleep disorders in children with Down syndrome: Stores and Stores reply","volume":"55","author":"Stores","year":"2013","journal-title":"Dev Med Child Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12913-017-2228-x","article-title":"In search of quality indicators for Down syndrome healthcare: a scoping review","volume":"17","author":"van den Driessen Mareeuw","year":"2017","journal-title":"BMC Health Serv Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ejhg.2008.122","article-title":"Twenty-year trends in prevalence and survival of Down syndrome","volume":"16","author":"Irving","year":"2008","journal-title":"Eur J Hum Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/eji.201445049","article-title":"Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome","volume":"45","author":"Carsetti","year":"2015","journal-title":"Eur J Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1016\/j.vaccine.2015.10.083","article-title":"Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings","volume":"33","author":"Valentini","year":"2015","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jaci.2013.10.010","article-title":"Impact of Down syndrome on the performance of neonatal screening assays for severe primary immunodeficiency diseases","volume":"133","author":"Verstegen","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jpeds.2005.07.022","article-title":"Intrinsic abnormalities of lymphocyte counts in children with down syndrome","volume":"147","author":"de Hingh","year":"2005","journal-title":"J Pediatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","article-title":"Intrinsic defect of the immune system in children with Down syndrome: a review","volume":"156","author":"Kusters","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrg.2016.154","article-title":"Down syndrome and the complexity of genome dosage imbalance","volume":"18","author":"Antonarakis","year":"2017","journal-title":"Nat Rev Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4161\/rna.7.5.12685","article-title":"Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins","volume":"7","author":"Elton","year":"2010","journal-title":"RNA Biol"},{"key":"B13","unstructured":"The proteins of human chromosome 21196205\n            GardinerK\n            CostaAC\n          17048356Am J Med Genet C Semin Med Genet2006"},{"key":"B14","doi-asserted-by":"publisher","first-page":"D154","DOI":"10.1093\/nar\/gkm952","article-title":"miRBase: tools for microRNA genomics","volume":"36","author":"Griffiths-Jones","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.gene.2013.07.055","article-title":"Identification of dysregulated microRNAs in lymphocytes from children with Down syndrome","volume":"530","author":"Xu","year":"2013","journal-title":"Gene"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1101\/gr.2090904","article-title":"Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome","volume":"14","author":"Lyle","year":"2004","journal-title":"Genome Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: new regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat Rev Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb0309-228","article-title":"Many roads to maturity: microRNA biogenesis pathways and their regulation","volume":"11","author":"Winter","year":"2009","journal-title":"Nat Cell Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaut.2009.02.012","article-title":"MicroRNA in autoimmunity and autoimmune diseases","volume":"32","author":"Pauley","year":"2009","journal-title":"J Autoimmun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12967-016-0893-x","article-title":"Regulatory mechanisms of microRNA expression","volume":"14","author":"Gulyaeva","year":"2016","journal-title":"J Transl Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1086\/519979","article-title":"Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes","volume":"81","author":"Sethupathy","year":"2007","journal-title":"Am J Hum Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nri2957","article-title":"MicroRNAs: the fine-tuners of Toll-like receptor signalling","volume":"11","author":"O'Neill","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/imr.12057","article-title":"miR-155: an ancient regulator of the immune system","volume":"253","author":"Vigorito","year":"2013","journal-title":"Immunol Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with 'antagomirs'","volume":"438","author":"Krutzfeldt","year":"2005","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jim.2015.07.006","article-title":"Direct uptake of Antagomirs and efficient knockdown of miRNA in primary B and T lymphocytes","volume":"426","author":"Haftmann","year":"2015","journal-title":"J Immunol Methods"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.4049\/jimmunol.167.7.3610","article-title":"Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome","volume":"167","author":"Bohnhorst","year":"2001","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.1997.tb52073.x","article-title":"Identification and cloning of genes expressed by human tonsillar B lymphocyte subsets","volume":"815","author":"Frazer","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"B29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1084\/jem.180.1.329","article-title":"Analysis of somatic mutation in five B cell subsets of human tonsil","volume":"180","author":"Pascual","year":"1994","journal-title":"J Exp Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.4049\/jimmunol.1403086","article-title":"Cutting edge: An in vivo reporter reveals active B cell receptor signaling in the germinal center","volume":"194","author":"Mueller","year":"2015","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","article-title":"Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas","volume":"120","author":"Victora","year":"2012","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1600-065X.2012.01112.x","article-title":"Roles of BCL6 in normal and transformed germinal center B cells","volume":"247","author":"Basso","year":"2012","journal-title":"Immunol Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.4049\/jimmunol.177.10.6930","article-title":"Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance","volume":"177","author":"Cattoretti","year":"2006","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De Silva","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal centres: role in B-cell physiology and malignancy","volume":"8","author":"Klein","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.it.2014.06.002","article-title":"Phenotype and functions of memory Tfh cells in human blood","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nri3447","article-title":"The good, the bad and the ugly - TFH cells in human health and disease","volume":"13","author":"Tangye","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ni.3054","article-title":"Pathophysiology of T follicular helper cells in humans and mice","volume":"16","author":"Ueno","year":"2015","journal-title":"Nat Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1177\/0961203314567750","article-title":"Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production","volume":"24","author":"Zhang","year":"2015","journal-title":"Lupus"},{"key":"B42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4049\/jimmunol.180.2.800","article-title":"CpG drives human transitional B cells to terminal differentiation and production of natural antibodies","volume":"180","author":"Capolunghi","year":"2008","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/eji.201646574","article-title":"B-cell activation with CD40L or CpG measures the function of B-cell subsets and identifies specific defects in immunodeficient patients","volume":"47","author":"Marasco","year":"2017","journal-title":"Eur J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"12970","DOI":"10.1038\/ncomms12970","article-title":"MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis","volume":"7","author":"Alivernini","year":"2016","journal-title":"Nat Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1042\/BST0360531","article-title":"Regulation of B- and T-cell differentiation by a single microRNA","volume":"36","author":"Turner","year":"2008","journal-title":"Biochem Soc Trans."},{"key":"B46","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.immuni.2008.04.002","article-title":"MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation","volume":"28","author":"Dorsett","year":"2008","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.immuni.2008.03.015","article-title":"MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase","volume":"28","author":"Teng","year":"2008","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/leu.2015.124","article-title":"Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo","volume":"29","author":"Morelli","year":"2015","journal-title":"Leukemia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1182\/blood-2014-02-553842","article-title":"Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias","volume":"124","author":"So","year":"2014","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/(SICI)1096-9136(199802)15:2<160::AID-DIA537>3.0.CO;2-J","article-title":"Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications","volume":"15","author":"Anwar","year":"1998","journal-title":"Diabet Med"},{"key":"B51","unstructured":"Prevalence of coeliac disease in Down's syndrome2637\n            CarnicerJ\n            FarreC\n            VareaV\n            VilarP\n            MorenoJ\n            ArtigasJ\n          11293446Eur J Gastroenterol Hepatol132001"},{"key":"B52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down's syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s13059-014-0445-8","article-title":"MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use","volume":"15","author":"Nana-Sinkam","year":"2014","journal-title":"Genome Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1084\/jem.20140338","article-title":"The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation","volume":"211","author":"Lu","year":"2014","journal-title":"J Exp Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","article-title":"microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells","volume":"27","author":"Vigorito","year":"2007","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ni.3348","article-title":"Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response","volume":"17","author":"Tellier","year":"2016","journal-title":"Nat Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1172\/JCI61716","article-title":"MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages","volume":"122","author":"Nazari-Jahantigh","year":"2012","journal-title":"J Clin Invest."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/eji.201747034","article-title":"Bcl6 promotes follicular helper T-cell differentiation and PD-1 expression in a Blimp1-independent manner in mice","volume":"47","author":"Xie","year":"2017","journal-title":"Eur J Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"8737649","DOI":"10.1155\/2017\/8737649","article-title":"Overexpression of chromosome 21 miRNAs may affect mitochondrial function in the hearts of Down Syndrome fetuses","volume":"2017","author":"Izzo","year":"2017","journal-title":"Int J Genomics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1101\/gad.1856210","article-title":"miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia","volume":"24","author":"Klusmann","year":"2010","journal-title":"Genes Dev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fmolb.2017.00046","article-title":"New insight into microRNA functions in cancer: oncogene-microRNA-tumor suppressor gene network","volume":"4","author":"Zhou","year":"2017","journal-title":"Front Mol Biosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.anndiagpath.2018.03.006","article-title":"microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia","volume":"34","author":"Tili","year":"2018","journal-title":"Ann Diagn Pathol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02683\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T04:38:40Z","timestamp":1542688720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02683\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2018.02683"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02683","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"article-number":"2683"}}